Explore more publications!
Chemicals Press Releases
Got News to Share?

Chemicals Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Chemicals Press Releases.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on October 8, 2025

Interstate Plastics Boise Supports Idaho Industries with Trusted Material Expertise
October 8, 2025

Interstate Plastics Boise Supports Idaho Industries with Trusted Material Expertise

Indeterminate EIN Presswire
HPS Flooring Completes an Epoxy Floor in a Plating Facility
October 8, 2025

HPS Flooring Completes an Epoxy Floor in a Plating Facility

Indeterminate EIN Presswire
Phthalate Risk Evaluation under TSCA: B&C’s October 30 Webinar Explores Potential Impacts to the Plastics Industry
October 8, 2025

Phthalate Risk Evaluation under TSCA: B&C’s October 30 Webinar Explores Potential Impacts to the Plastics Industry

Indeterminate EIN Presswire
Finland Welcomes Global Scientists: Quantum Breakthrough Inspires New Era of Research Collaboration
October 8, 2025

Finland Welcomes Global Scientists: Quantum Breakthrough Inspires New Era of Research Collaboration

Indeterminate EIN Presswire
Dr. Thomas Murphy selected as Top Chemical Engineer of the Year by IAOTP
October 8, 2025

Dr. Thomas Murphy selected as Top Chemical Engineer of the Year by IAOTP

Indeterminate EIN Presswire
Global Sandwich Panels Market to Reach USD 33.7 Billion by 2035, Expanding at 5.7% CAGR | Transparency Market Research
October 8, 2025

Global Sandwich Panels Market to Reach USD 33.7 Billion by 2035, Expanding at 5.7% CAGR | Transparency Market Research

Indeterminate EIN Presswire
Sodium Cocoyl Glycinate Market to Reach USD 327.6 Mn by 2035, Growing at 4.8% CAGR | TMR
October 8, 2025

Sodium Cocoyl Glycinate Market to Reach USD 327.6 Mn by 2035, Growing at 4.8% CAGR | TMR

Indeterminate EIN Presswire
Global White Coal Market to Reach USD 6.1 Bn by 2035, Driven by Rising Demand for Eco-Friendly Energy | TMR
October 8, 2025

Global White Coal Market to Reach USD 6.1 Bn by 2035, Driven by Rising Demand for Eco-Friendly Energy | TMR

Indeterminate EIN Presswire
Global Magnesium Chloride Market Size, Share, Forecast & Trends 2025-2032 | Revenue to Reach USD 1.63 Billion
October 8, 2025

Global Magnesium Chloride Market Size, Share, Forecast & Trends 2025-2032 | Revenue to Reach USD 1.63 Billion

Indeterminate EIN Presswire
EmberOT v3.4 Release Expands ICS/SCADA Protocol Coverage, Strengthens Threat Detection, & Accelerates Asset Intelligence
October 8, 2025

EmberOT v3.4 Release Expands ICS/SCADA Protocol Coverage, Strengthens Threat Detection, & Accelerates Asset Intelligence

Indeterminate EIN Presswire
Ammonia Cracking Catalysts Market to Hit USD 136.6 Million by 2031, Driven by Hydrogen Transition and Clean Energy Push
October 8, 2025

Ammonia Cracking Catalysts Market to Hit USD 136.6 Million by 2031, Driven by Hydrogen Transition and Clean Energy Push

Indeterminate EIN Presswire
United States Smart Polymers Market Surge Driven by Demand for Advanced Healthcare and Electronics Solutions 2025-2032
October 8, 2025

United States Smart Polymers Market Surge Driven by Demand for Advanced Healthcare and Electronics Solutions 2025-2032

Indeterminate EIN Presswire
Nilo Therapeutics startet mit einer Serie-A-Finanzierung in Höhe von 101 Mio. USD zur Entwicklung einer neuen Medikamentenklasse, die auf neuronale Schaltkreise bei Immunerkrankungen abzielt, und ernennt Kim Seth zum Chief Executive Officer
October 8, 2025

Nilo Therapeutics startet mit einer Serie-A-Finanzierung in Höhe von 101 Mio. USD zur Entwicklung einer neuen Medikamentenklasse, die auf neuronale Schaltkreise bei Immunerkrankungen abzielt, und ernennt Kim Seth zum Chief Executive Officer

Indeterminate GlobeNewswire
Nilo Therapeutics se lanza con un financiamiento Serie A de 101 millones de dólares para avanzar una nueva clase de medicamentos dirigidos a los circuitos neuronales en enfermedades inmunológicas y nombra a Kim Seth como director ejecutivo
October 8, 2025

Nilo Therapeutics se lanza con un financiamiento Serie A de 101 millones de dólares para avanzar una nueva clase de medicamentos dirigidos a los circuitos neuronales en enfermedades inmunológicas y nombra a Kim Seth como director ejecutivo

Indeterminate GlobeNewswire
Lancement de Nilo Therapeutics avec un financement de série A de 101 millions de dollars en vue de développer une nouvelle classe de médicaments ciblant les circuits neuronaux dans les maladies immunitaires, et nomination de Kim Seth au poste de…
October 8, 2025

Lancement de Nilo Therapeutics avec un financement de série A de 101 millions de dollars en vue de développer une nouvelle classe de médicaments ciblant les circuits neuronaux dans les maladies immunitaires, et nomination de Kim Seth au poste de…

Indeterminate GlobeNewswire
Nilo Therapeutics מושקה עם מימון סדרה A של 101 מיליון דולר לקידום סוג חדש של תרופות המכוונות למעגלים עצביים במחלות חיסוניות וממנה את קים סת' למנכ"ל
October 8, 2025

Nilo Therapeutics מושקה עם מימון סדרה A של 101 מיליון דולר לקידום סוג חדש של תרופות המכוונות למעגלים עצביים במחלות חיסוניות וממנה את קים סת' למנכ"ל

Indeterminate GlobeNewswire
ナイロ・セラピューティクス (Nilo Therapeutics)、免疫疾患における神経回路を標的とする新しい種類の医薬品開発を推進するため、1億100万米ドル (約154億1,290万円) のシリーズA資金調達を実施し、キム・セス博士 (Kim Seth, Ph.D.) を最高経営責任者 (CEO) に任…
October 8, 2025

ナイロ・セラピューティクス (Nilo Therapeutics)、免疫疾患における神経回路を標的とする新しい種類の医薬品開発を推進するため、1億100万米ドル (約154億1,290万円) のシリーズA資金調達を実施し、キム・セス博士 (Kim Seth, Ph.D.) を最高経営責任者 (CEO) に任…

Indeterminate GlobeNewswire
Nilo Therapeutics diluncurkan dengan pendanaan Seri A senilai 101 juta dolar AS untuk mengembangkan kelas baru obat-obatan yang menargetkan sirkuit saraf pada penyakit imun, serta menunjuk Kim Seth sebagai Direktur Utama
October 8, 2025

Nilo Therapeutics diluncurkan dengan pendanaan Seri A senilai 101 juta dolar AS untuk mengembangkan kelas baru obat-obatan yang menargetkan sirkuit saraf pada penyakit imun, serta menunjuk Kim Seth sebagai Direktur Utama

Indeterminate GlobeNewswire
Nilo Therapeutics dilancarkan dengan pembiayaan Siri A sebanyak $101 juta untuk membangunkan kelas baharu ubat-ubatan yang menyasarkan litar neural dalam penyakit imun, serta melantik Kim Seth sebagai Ketua Pegawai Eksekutif
October 8, 2025

Nilo Therapeutics dilancarkan dengan pembiayaan Siri A sebanyak $101 juta untuk membangunkan kelas baharu ubat-ubatan yang menyasarkan litar neural dalam penyakit imun, serta melantik Kim Seth sebagai Ketua Pegawai Eksekutif

Indeterminate GlobeNewswire
Nilo Therapeutics é lançada com financiamento de US $101 milhões da Série A para promover uma nova classe de medicamentos direcionados a circuitos neurais em doenças imunológicas e nomeia Kim Seth como CEO
October 8, 2025

Nilo Therapeutics é lançada com financiamento de US $101 milhões da Série A para promover uma nova classe de medicamentos direcionados a circuitos neurais em doenças imunológicas e nomeia Kim Seth como CEO

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions